Integral Health Asset Management, LLC Denali Therapeutics Inc. Transaction History

Integral Health Asset Management, LLC

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$14.96 - $23.22 $4.86 Million - $7.55 Million	325,000 New	325,000 $7.55 Million
Q3 2022 Nov 14, 2022	BUY	$25.97 - $38.53 $2.99 Million - $4.43 Million	115,000 New	115,000 $3.53 Million
Q2 2022 Aug 03, 2022	SELL	$20.88 - $35.19 $542,880 - $914,939	-26,000 Closed	0 $0
Q1 2022 May 12, 2022	SELL	$29.0 - $47.27 $2.15 Million - $3.5 Million	-74,000 Reduced 74.0%	26,000 $836,000
Q4 2021 Feb 02, 2022	BUY	$42.59 - $55.02 $1.06 Million - $1.38 Million	25,000 Added 33.33%	100,000 $4.46 Million
Q3 2021 Nov 12, 2021	SELL	$48.48 - $78.23 $290,880 - $469,380	-6,000 Reduced 7.41%	75,000 $3.78 Million
Q2 2021 Aug 30, 2021	SELL	$50.3 - $78.44 $4.07 Million - $6.35 Million	-81,000 Reduced 50.0%	81,000 $6.35 Million
Q2 2021 Aug 13, 2021	BUY	$50.3 - $78.44 $3.27 Million - $5.1 Million	65,000 Added 67.01%	162,000 $12.7 Million
Q1 2021 May 10, 2021	BUY	$53.8 - $81.53 $2.13 Million - $3.22 Million	39,500 Added 68.7%	97,000 $5.54 Million
Q4 2020 Feb 16, 2021	SELL	$36.89 - $93.56 $3.97 Million - $10.1 Million	-107,500 Reduced 65.15%	57,500 $4.82 Million
Q3 2020 Nov 16, 2020	BUY	$23.13 - $38.84 $809,550 - $1.36 Million	35,000 Added 26.92%	165,000 $5.91 Million
Q2 2020 Aug 14, 2020	BUY	$16.01 - $28.82 $640,400 - $1.15 Million	40,000 Added 44.44%	130,000 $3.14 Million
Q1 2020 May 15, 2020	BUY	$14.2 - $27.98 $1.28 Million - $2.52 Million	90,000 New	90,000 $1.58 Million

227

119M

60.6K

48.4K

Ticker DNLI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 134,174,000
Market Cap $2.77B
Description
Denali Therapeutics Inc., a biopharmaceutical company, discovers and develops therapeutic candidates for neurodegenerative diseases in the United States. It offers leucine-rich repeat kinase 2 (LRRK2) inhibitor product candidate, including BIIB122/DNL151, a small molecule inhibitor, which is in phase I and phase Ib clinical trials for the treatm...

Get notified when there are updates to the investment portfolio of Integral Health Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Integral Health Asset Management, LLC with notifications on news.